Latest Period
Q4 2025
Security Snapshot
Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) Institutional Ownership
CUSIP: 69012T305
13F Institutional Holders and Ownership History from Q1 2023 to Q1 2026
Institutions Reporting
52
Shares (Excl. Options)
6,820,797
Price
$1.58
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Symbol
- OTLK on Nasdaq
- Shares outstanding
- 120,049,038
- Price per share
- $0.25
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 6,820,797
- Total reported value
- $10,777,161
- % of total 13F portfolios
- 0%
- Share change
- +2,400,449
- Value change
- +$3,854,437
- Number of holders
- 52
- Price from insider filings
- $0.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 69012T305.
- 52 institutions reported positions in Q4 2025.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 52 to 11 between Q4 2025 and Q1 2026.
- Reported value moved from $10,777,161 to $261,413.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 52 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 69012T305:
Significant Owners of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GMS Ventures & Investments | 50% | +21% | $45,303,849 | +$20,057,142 | 29,040,929 | +79% | GMS VENTURES & INVESTMENTS | 27 May 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $1,232,834 | 5,990,447 | Mitchell P. Kopin | 22 Apr 2026 | |||
| SPHERA FUNDS MANAGEMENT LTD. | 4.7% | -40% | $4,983,092 | +$920,239 | 3,153,856 | +23% | Sphera Funds Management Ltd. | 31 Dec 2025 |
| Empery Asset Management, LP | 5% | -32% | $2,472,925 | -$914,455 | 2,332,948 | -27% | Empery Asset Management, LP | 30 Sep 2025 |
| GREAT POINT PARTNERS LLC | 5% | -23% | $4,484,400 | 2,220,000 | 0% | Great Point Partners, LLC | 30 Jun 2025 | |
| TANG CAPITAL PARTNERS LP | 6.4% | $2,624,703 | 1,682,502 | TANG CAPITAL MANAGEMENT, LLC | 31 Dec 2024 | |||
| TANG CAPITAL MANAGEMENT LLC | 3.4% | -37% | $3,030,000 | -$808,000 | 1,500,000 | -21% | TANG CAPITAL MANAGEMENT, LLC | 30 Jun 2025 |
As of 31 Dec 2025, 52 institutional investors reported holding 6,820,797 shares of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK). This represents 5.7% of the company’s total 120,049,038 outstanding shares.
Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,270,068 | $261,413 | +$34,283 | $0.21 | 11 |
| 2025 Q4 | 6,820,797 | $10,777,161 | +$3,854,437 | $1.58 | 52 |
| 2025 Q3 | 4,077,199 | $4,321,292 | -$2,295,886 | $1.06 | 53 |
| 2025 Q2 | 5,938,598 | $9,501,555 | -$1,298,121 | $1.60 | 63 |
| 2025 Q1 | 7,084,422 | $8,644,858 | +$2,800,480 | $1.22 | 61 |
| 2024 Q4 | 4,545,632 | $8,587,260 | -$17,551,788 | $1.89 | 60 |
| 2024 Q3 | 7,927,898 | $42,334,234 | -$3,223,883 | $5.34 | 65 |
| 2024 Q2 | 8,042,692 | $59,354,216 | +$2,234,341 | $7.38 | 63 |
| 2024 Q1 | 7,236,418 | $86,189,121 | +$86,127,774 | $11.94 | 53 |
| 2023 Q3 | 34,194 | $7,557 | $0.22 | 1 | |
| 2023 Q2 | 34,194 | $59,498 | $1.74 | 1 | |
| 2023 Q1 | 34,194 | $37,271 | +$37,271 | $1.09 | 1 |